drugset / Trial / NCT01092221

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

NCT01092221

Phase 3 Completed 180 enrolled Sheba Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of the study is to evaluate the efficacy of allopurinol, compared to placebo, as add-on to mood stabilizers and/or antipsychotic in the treatment of patients with bipolar disorder, in a manic episode.

Timeline

Start
2010-05
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 300 mg